Category: Prescription Drugs
Prescription Drugs market research reports by DelveInsight
-
FLUMIST QUADRIVALENT Drug Insight and Market Forecast − 2032
FLUMIST QUADRIVALENT Drug Insight and Market Forecast − 2032 “FLUMIST QUADRIVALENT Drug Insight and Market Forecast – 2032” report provides comprehensive insights about FLUMIST QUADRIVALENT for seasonal influenza in the six major markets. A detailed picture of the FLUMIST QUADRIVALENT for seasonal i ... Read More
-
Quadrivalent VLP vaccine Emerging Drug Insight and Market Forecast − 2032
Quadrivalent VLP vaccine Emerging Drug Insight and Market Forecast − 2032 “Quadrivalent VLP vaccine Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about quadrivalent VLP vaccine for seasonal influenza in the seven major markets. A detailed picture of the qua ... Read More
-
NanoFlu Emerging Drug Insight and Market Forecast − 2032
NanoFlu Emerging Drug Insight and Market Forecast − 2032 “NanoFlu Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about NanoFlu for seasonal influenza in the seven major markets. A detailed picture of the NanoFlu for seasonal influenza in the 7MM, i.e., the U ... Read More
-
DEXTENZA Drug Insight and Market Forecast − 2032
DEXTENZA Drug Insight and Market Forecast − 2032 “DEXTENZA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about DEXTENZA for acute ocular pain (AOP) in the United States. A detailed picture of the DEXTENZA for acute ocular pain in the United States for the study peri ... Read More
-
OCS-01 Emerging Drug Insight and Market Forecast − 2032
OCS-01 Emerging Drug Insight and Market Forecast − 2032 “OCS-01 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about OCS-01 for acute ocular pain (AOP) in the eight major markets. A detailed picture of the OCS-01 for acute ocular pain in the 8MM, i.e., the U ... Read More
-
APP13007 Emerging Drug Insight and Market Forecast − 2032
APP13007 Emerging Drug Insight and Market Forecast − 2032 “APP13007 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about APP13007 for acute ocular pain (AOP) in the eight major markets. A detailed picture of the APP13007 for acute ocular pain in the 8MM, i.e ... Read More
-
Crovalimab Emerging Drug Insight and Market Forecast − 2032
Crovalimab Emerging Drug Insight and Market Forecast − 2032 “Crovalimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about crovalimab for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the crovalimab for PNH in ... Read More
-
Pozelimab Emerging Drug Insight and Market Forecast − 2032
Pozelimab Emerging Drug Insight and Market Forecast − 2032 “Pozelimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about pozelimab for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the pozelimab for PNH in the ... Read More
-
IMFINZI Emerging Drug Insight and Market Forecast − 2032
IMFINZI Emerging Drug Insight and Market Forecast − 2032 “IMFINZI Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about IMFINZI for malignant pleural mesothelioma (MPM) in the seven major markets. A detailed picture of the IMFINZI for MPM in the 7MM, i.e., th ... Read More
-
Bertilimumab Emerging Drug Insight and Market Forecast − 2032
Bertilimumab Emerging Drug Insight and Market Forecast − 2032 “Bertilimumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about bertilimumab for bullous pemphigoid in the seven major markets. A detailed picture of the bertilimumab for bullous pemphigoid in ... Read More
-
Regorafenib Drug Insight and Market Forecast − 2032
Regorafenib Drug Insight and Market Forecast − 2032 “Regorafenib Drug Insight and Market Forecast – 2032” report provides comprehensive insights about regorafenib for glioblastoma multiforme (GBM) in the seven major markets. A detailed picture of the regorafenib for GBM in the 7MM, i.e., the United ... Read More
-
Netarsudil Emerging Drug Insight and Market Forecast − 2032
Netarsudil Emerging Drug Insight and Market Forecast − 2032 “Netarsudil Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about netarsudil for Fuchs Endothelial Corneal Dystrophy (FECD) in the seven major markets. A detailed picture of the netarsudil for FECD i ... Read More
-
RP-L102 Emerging Drug Insight and Market Forecast − 2032
RP-L102 Emerging Drug Insight and Market Forecast − 2032 “RP-L102 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about RP-L102 for fanconi anemia in the seven major markets. A detailed picture of the RP-L102 for fanconi anemia in the 7MM, i.e., the United St ... Read More
-
LNP023 Emerging Drug Insight and Market Forecast − 2032
LNP023 Emerging Drug Insight and Market Forecast − 2032 “LNP023 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LNP023 for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the LNP023 for PNH in the 7MM, i.e., t ... Read More
-
JointStem Emerging Drug Insight and Market Forecast − 2032
JointStem Emerging Drug Insight and Market Forecast − 2032 “JointStem Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about JointStem for osteoarthritis in the six major markets. A detailed picture of the JointStem for osteoarthritis in the 6MM, i.e., the Uni ... Read More
-
NAMUSCLA Emerging Drug Insight and Market Forecast − 2032
NAMUSCLA Emerging Drug Insight and Market Forecast − 2032 “NAMUSCLA (Mexiletine) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about NAMUSCLA for Myotonic Dystrophy in the seven major markets. A detailed picture of the NAMUSCLA for myotonic dystrophy in the ... Read More
-
Itacitinib Emerging Drug Insight and Market Forecast − 2032
Itacitinib Emerging Drug Insight and Market Forecast − 2032 “Itacitinib Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about itacitinib for Bronchiolitis Obliterans Syndrome (BOS) in the seven major markets. A detailed picture of the itacitinib for bronchiol ... Read More
-
AMZ001 Emerging Drug Insight and Market Forecast − 2032
AMZ001 Emerging Drug Insight and Market Forecast − 2032 “AMZ001 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about AMZ001 for osteoarthritis in the six major markets. A detailed picture of the AMZ001 for osteoarthritis in the 6MM, i.e., the United States, ... Read More
-
TEMODAR Drug Insight and Market Forecast − 2032
TEMODAR Drug Insight and Market Forecast − 2032 “TEMODAR Drug Insight and Market Forecast – 2032” report provides comprehensive insights about TEMODAR for glioblastoma multiforme (GBM) in the seven major markets. A detailed picture of the TEMODAR for GBM in the 7MM, i.e., the United States, EU4 (Ger ... Read More
-
PULMOZYME Drug Insight and Market Forecast − 2032
PULMOZYME Drug Insight and Market Forecast − 2032 “PULMOZYME Drug Insight and Market Forecast – 2032” report provides comprehensive insights about PULMOZYME for Cystic Fibrosis in the six major markets. A detailed picture of the PULMOZYME for cystic fibrosis in the 7MM, i.e., the United States, EU4 ... Read More
-
Lerapolturev + Pembrolizumab Emerging Drug Insight and Market Forecast − 2032
Lerapolturev + Pembrolizumab Emerging Drug Insight and Market Forecast − 2032 “Lerapolturev + Pembrolizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about lerapolturev + pembrolizumab for glioblastoma multiforme (GBM) in the seven major markets. A deta ... Read More
-
SAGE-217 Emerging Drug Insight and Market Forecast − 2032
SAGE-217 Emerging Drug Insight and Market Forecast − 2032 “SAGE-217 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SAGE-217 for Postpartum depression (PPD) in the United States. A detailed picture of the SAGE-217 for PPD in the United States for the st ... Read More
-
DUPIXENT Drug Insight and Market Forecast − 2032
DUPIXENT Drug Insight and Market Forecast − 2032 “DUPIXENT Drug Insight and Market Forecast – 2032” report provides comprehensive insights about DUPIXENT for Eosinophilic esophagitis (EoE) in the seven major markets. A detailed picture of the DUPIXENT for EoE in the 7MM, i.e., the United States, EU4 ... Read More
-
LOTEMAX SM Drug Insight and Market Forecast − 2032
LOTEMAX SM Drug Insight and Market Forecast − 2032 “LOTEMAX SM Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LOTEMAX SM for acute ocular pain (AOP) in the United States. A detailed picture of the LOTEMAX SM for acute ocular pain in the United States for the st ... Read More
-
TLC599 Emerging Drug Insight and Market Forecast − 2032
TLC599 Emerging Drug Insight and Market Forecast − 2032 “TLC599 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about TLC599 for osteoarthritis in the six major markets. A detailed picture of the TLC599 for osteoarthritis in the 6MM, i.e., the United States, ... Read More
Research Assistance
